Using MRI may help researchers predict which adults are likely to develop Alzheimer’s disease, according to a new study published online and in the June issue of Radiology.
Using MRI may help researchers predict which adults are likely to develop Alzheimer’s disease, according to a new study published online and in the June issue of Radiology.
Analyzing MRI exams of healthy patients as well as those with mild cognitive impairment (MCI) and early Alzheimer’s, researchers examined specific biomarkers of the disease process. Researchers measured the thickness of the cerebral cortex - which is the outermost later that plays a key role in memory, attention, thought, and language - and observed the pattern of thinning to determine risk of Alzheimer’s disease (AD).
“MRI is very sensitive to brain atrophy,” said Linda K. McEvoy, PhD, assistant professor in the Department of Radiology at the University of California, San Diego School of Medicine. “There’s a pattern of cortical thinning associated with AD that indicates the patient is more likely to progress to AD.”
The study, which used exams from the Alzheimer’s Disease Neuroimaging Initiative, included a baseline MRI exam and a second MRI performed a year later on 203 healthy adults, 317 patients with MCI, and 164 patients with late-onset AD. Researchers calculated that the patients with MCI had a one-year risk of developing AD ranging from 3 percent to 40 percent.
Combining the results of the baseline MRI and the one performed a year later, researchers were able to calculate a more informed rate of change. Patients with mild cognitive impairment had a risk of disease progression between 3 percent and 69 percent, based on the MRI exams, researchers said.
“MRI provides substantially more informative, patient-specific risk estimates,” McEvoy said in a statement.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
New bpMRI Study Suggests AI Offers Comparable Results to Radiologists for PCa Detection
April 15th 2025Demonstrating no significant difference with radiologist detection of clinically significant prostate cancer (csPCa), a biparametric MRI-based AI model provided an 88.4 percent sensitivity rate in a recent study.
Could Ultrafast MRI Enhance Detection of Malignant Foci for Breast Cancer?
April 10th 2025In a new study involving over 120 women, nearly two-thirds of whom had a family history of breast cancer, ultrafast MRI findings revealed a 5 percent increase in malignancy risk for each second increase in the difference between lesion and background parenchymal enhancement (BPE) time to enhancement (TTE).